ESSA Pharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; ESSA Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
